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CASE REPORT
Abstract—Introduction: Venous leg ulcers (VLU) occur in
1% of the adult population and are associated with chronic
disability, diminished quality of life and high health-care costs.
Treatment is often slow, difficult and recurrence is high because
of inappropriate conditions of the wound bed.
Patients and Methods: This study involves 14 patients with
chronic venous ulcers larger than 100 cm2 treated with negative
pressure wound therapy (NPWT). Patients underwent a radical
debridement of all devitalized tissues and partial stripping of
an insufficient great saphenous vein in the first operation. After
adequate haemostasis, NPWT kit was applied. Once the wounds
were determined to be clean and adequate granulation tissue
formation was achieved, split-thickness skin grafts were applied.
Dressing impregnated with neutral triglycerides and silver ions
was used as a first layer and the black polyurethane NPWT
foam was applied over it. The pain assessment was performed
for 7 patients using 10 cm visual analog scale (VAS).
Results: The mean number of NPWT dressing changes prior
to grafting was 5.8. The mean number of NPWT foam changes
was 2.8 after skin grafting. We accomplished complete healing of
92% of applied skin grafts surface. One patient had recurrence
of venous ulcers in the follow-up period. Moreover, one patient
required regrafting.
Conclusions: The application of NPWT provides quick
wound-bed preparation and high graft take in venous ulcer
treatment.
Keywords—venous ulcers, negative pressure wound therapy,
chronic wound, chronic venous insufficiency, skin graft, silver,
pain
I. INTRODUCTION
THE venous leg ulcers (VLU) occur in 1% of adultpopulation and are associated with chronic disability,
diminished quality of life and high health-care costs. Chronic
venous insufficiency is the main cause of venous ulcers
development.1 Increased pressure in the venous system lead
to elevated pressure in the capillaries. That allows large
molecules and cells to escape into the interstitial fluid.
Accumulation of blood cells and fibrinogen deposits inhibits
collagen production and plugging the capillaries which lead
to tissue ischaemia. Secretion of growth factors, cytokines
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and matrix metalloproteinases is deregulated. All these un-
favourable factors disrupts the skin’s microcirculation, stim-
ulate inflammation and create a non-healing environment.2
Treatment is often slow, difficult and challenging. Poor prog-
nostic factors include large size of the ulcer and prolonged
duration. Moreover, the recurrence rates may be as high as
70%.
The best clinical outcomes are achieved through a multi-
modal care pathway, which includes nutrition, debridement,
vascular surgical intervention and compression therapy along
with advanced wound management.3, 4
The negative pressure wound therapy (NPWT) also known
as the vacuum-assisted closure (VAC) is very fast developing
method of the wounds treatment. It perfectly executes TIME
rule (T- tissue debridement, I- infection and inflammation
control, M - moisture balance and E -epidermalization stimu-
lation). The beneficial effects of NPWT on the wound healing
include: mechanical drainage, moist environment, reduction
of swelling, stimulation of granulation tissue formation, in-
crease in local blood, neoangiogenesis, reduction of bacterial
colonization.5
II. PATIENTS AND METHODS
From March 2012 to December 2015, 31 patients with
chronic venous ulcers were treated with NPWT at the De-
partment of General Surgery, John Paul II Memorial Hospital
in Bełchatów. The venous origin of the ulcer was confirmed
by the venous Doppler sonography and ABI measurement.
Patients with diabetic or ischaemic ulcers and patients with
arterial insufficiency of the lower extremity (ABI <0,9) were
not included in the study. Finally, 14 patients with venous
ulcers larger than 100 cm2 were qualified to the retrospective
analysis. The cultural swab was taken from ulcers on the
admission day. The antibiotics were administered according
to culture and susceptibility test results. The surface of wound
was measured by projection of the ulcers onto transparent foil
with preprinted 1cm2 measures. Half/squares were rounded
up to 1cm2.
At the beginning of hospital stay, crossectomy and partial
stripping of insufficient great saphenous vein (up to ulcer
level) were performed in all patients. The insufficient perfo-
rator veins were also ligated if detected. Moreover all patients
underwent a radical debridement of all necrotic tissues, fibrin
Medigent.org cb DOI: 10.18487/npwtj.v4i2.26
18 NEGATIVE PRESSURE WOUND THERAPY JOURNAL, VOL. 4, NO. 2, 2017
Table I
CHARACTERISTICS OF THE PATIENTS
Patient
Age
Sex Duration of the
ulcer (years)
Surface of the ul-
cer [cm2]
Number of
NPWT dressing
changes prior to
grafting
Number of
NPWT dressing
changes after
grafting
Percentage of vital surface
of mesh grafts
1 58 F 3 220 6 2 99
2 60 F 4 345 5 2 95
3 75 F 20 180 3 4 98
4 50 F 10 270 10 3 90
5 69 M 7 320 8 3 90
6 70 M 5 110 6 2 93
7 58 M 6 105 4 2 99
8 62 M 3 150 8 4 88
9 73 F 1 110 3 3 9
10 56 F 2 135 3 3 95
11 67 M 3 120 5 2 90
12 59 F 4 720* 9 3 96
13 80 F 1 280 5 3 95
14 60 F 1 190 6 3 70
* venous ulcers of both legs
deposits and ointment remained during the first operation
(Fig. 1)A,B (Fig. 2)A (Fig. 4)A,B. The polyurethane foam
(VivanoMed Foam, PAUL HARTMANN AG, Germany) was
applied to the ulcer and the pump was set to a continuous
negative pressure of -120 mm Hg. Dressings were changed
every second day. To improve patient comfort during the
dressing change — 1% lidocaine was administered into
the foam 30 minutes earlier. After 48 hours, the pressure
mode was switched to intermittent negative pressure at -
120 mmHg/-20 mmHg. Once the wounds were determined
to be clean by clinical assessment and adequate granulation
tissue formation was achieved — the meshed split-thickness
skin grafts (SGTS) were applied (Fig. 1)C,D (Fig. 2)B (Fig.
3)B (Fig. 4)C. The Atrauman AG (non-adherent, polyester
tulle, impregnated with neutral triglycerides and silver ions,
PAUL HARTMANN AG, Germany) was used as a primary
dressing for skin grafts and covered with NPWT dressing kit
with continuous negative pressure of 75–100 mm Hg (Fig.
1)E,F. The NPWT dressings were changed on the third day
after grafts application. We removed only polyurethane foam,
however, the primary dressing (Atrauman AG) remained
untouched. The whole dressing (NPWT and polyester tulle
with silver ions) was changed on 5th or 6th day after grafts
application. Negative pressure wound therapy was continued
until it was considered that the grafts uptake was complete
(Fig. 1)G (Fig. 2) C (Fig. 3)C (Fig. 4)D.
The pain assessment was performed for 7 patients using
10 cm visual analog scale (VAS). The third-class medical
compression stockings were recommended upon patient’s’
release from the hospital. The patients were examined on
monthly follow-up visits after discharge. (Fig. 1)H (Fig.
2)D(Fig. 3)D.
III. RESULTS
We treated 14 patients (9 women and 5 men) with venous
ulcers larger than 100 cm2. A mean age of the patients was
64.07 years (range 56–80 years). The ulcer surface area was
from 105 cm2 to 720 cm2 (one patient had ulcerations on
Figure 1. Patient no. 4 in Table 1; a) the wound at the moment of admission;
b) the wound after debridement; c) the wound bed filled with granulation
tissue after 20 days of NPWT; d,e,f) application of meshed split-thickness
skin grafts covered with silver impregnated dressing and NPWT; g) the
wound at the moment of discharge from the hospital; h) the wound 3 months
after discharge from the hospital;
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Figure 2. Patient no. 12 in Table 1; a) wounds of both legs at the moment
of admission; b) the wounds bed filled with granulation tissue after 20 days
of NPWT; c) the wounds at the moment of discharge from the hospital; d)
the wound 2 months after discharge from the hospital
Figure 3. Patient no. 11 in Table 1; a) the wounds at the moment of
admission; b) the wound bed filled with granulation tissue after 6 days of
NPWT; c) the wounds at the moment of discharge from the hospital; d) the
wound 3 months after discharge from the hospital
both legs). The mean ulcer duration prior to admission to
our ward was 5 years (range 1-20 years). The mean number
NPWT dressing changes prior to skin grafting were 5.8 (3-10
changes) and 2.8 after grafting (2-4 changes). (Tab. I)
All patients reported a little higher pain level during
therapy compared with their pain level before treatment and
much higher during dressing change so then they required
additional painkillers. The pain level decrease during hospi-
talization even when the foam was changed. (Tab. II)
One patient had recurrence of venous ulcers 2 months after
discharge from the hospital. One patient required regrafting
due to only 70 % take rate of SGTS (Fig. 4)E.
IV. DISCUSSION
Experience of vacuum therapy used in medicine has a
long history and dates back to the ancient times. However
important milestone in vacuum application was introduced by
the German surgeon Bier and later by his student Klapp at
the beginning of 20th century. Their suction pump was used
for removal of the infectious materials in acute inflammatory
diseases of the soft tissue and the purulent wounds or
diabetic gangrene of feet. The negative pressure therapy for
the treatment of wounds was popularized by Argenta and
Morykwas in 1997, who described the use of subatmospheric
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pressure through a suction applied to polyurethane foam to
improve wound healing.6
The accurate mechanism of the NPWT action is not clear
however it gives the number of beneficial clinical effects.
It facilitates wound cleansing, creates a moist environment,
establishes the fluid balance by removal of the exudate
from the wound, reduces the tissue edema, contracts the
wound, mechanically stimulates the wound bed, improves
microcirculation, stimulates angiogenesis and the formation
of granulation tissue, reduces bacterial load and the risk of
infection.7–11
The application of the topical negative pressure therapy has
been shown to accelerate debridement and promote healing
in many different types of wounds.12 Lore’ e et al. applied the
vacuum-assisted closure to improve the quality of the wound
bed in VLU and they noticed that the median percentage
reduction in fibrinous tissue was 28% on day three and 40%
on day six of therapy.13 Vuerstaek et al. in a randomized
controlled trial showed that the negative pressure was able
to prepare wound bed of venous ulcer significantly faster for
surgical closure than in the control group. Moreover, costs of
conventional wound care were higher than those of NPWT
therapy.14
Table II
PAIN LEVEL DURING NPWT
Pain level on
VAS scale
(average for 7
patients)
Time of therapy
3,1 Moment of admission;
3,9 During NPWT, at the beginning of therapy;
6,3 During dressing change, at the beginning of NPWT
therapy;
3,4 During NPWT, at the end of therapy;
5,6 During dressing change, at the end of therapy;
According to the International Expert Panel on Negative
Pressure Wound Therapy (NPWT-EP) recommendations — if
compression therapy is not efficacious, the NPWT should be
used to prepare the wound for surgical closure or to progress
to wound closure by secondary intention.12
Following wound bed preparation, closure of venous leg
ulcers is commonly carried out by skin grafting. The benefits
of NPWT to support skin grafts in different types of wounds
were repeatedly reported15–18 as well as in venous ulcers.19
The NPWT demonstrated increase in grafts take rate and
improvement in graft quality. Thanks to the negative pressure,
the graft adheres to its bed strictly, and interstitial edema re-
sulting from the venous insufficiency is effectively removed.
The results of study performed by Korber et al. revealed
complete healing in 92.9% of meshed grafts in which they
had applied VAC compared to 67.4% in the control group
without postoperative VAC therapy.20 Similar improvement
was reported by Vuerstaek.14
In our study, we used polyester tulle, impregnated with
neutral triglycerides and silver ions as a primary dressing for
skin grafts. The usefulness of silver as an antimicrobial agent
has been known since antiquity and is well established.21 The
antimicrobial effect of silver is mediated by the presence of
the highly reactive Ag+ cation which is disruptive to many
aspects of microorganism metabolism. The mechanism of
action includes damage to the bacterial cell wall, blockage
of transport and enzyme systems such as the respiratory
cytochromes, alteration of proteins and binding of micro-
bial deoxyribonucleic acid and ribonucleic acid to prevent
transcription and division.22 Silver is regarded as a broad-
spectrum agent and shows activity against the pathogens
such as Stapylocoocus aureus and Pseudomonas spp., which
frequently colonizes chronic venous ulcers.23
Despite its advantages in treating infected wounds, sil-
ver has been demonstrated to be cytotoxic to human ker-
atinocytes and fibroblasts in vitro.21, 24 However, the clini-
cal correlation to support this finding remains unclear.22, 25
Some authors suggest that the human body has complex
homeostatic mechanisms and silver might have different
effects in vivo than in vitro.22, 26 However, we believe that
antimicrobial characteristics of silver ions preponderate its
cytotoxic effect. We tried to combine beneficial effect of
Ag cations with advantages of VAC therapy. This strategy
seems to be promising because we accomplished complete
healing of 92% of applied skin grafts surface. Hence, ran-
domized control group studies will be necessary to confirm
these hypothesis. Pain is a common side effect of NPWT
affecting quality of life and even precluding some patients
from continuing with the treatment. Many studies reported
significantly higher pain levels during therapy compared
with their pain levels before treatment.27–29 Moreover, high
sensation is experienced during dressing change, especially
in foam-based NPWT. It may be due to wound bed disruption
and mechanical tissue damage when the foam and adhering
tissue are torn from the wound bed [30]. One method that
has been described to reduce pain is to replace the foam
with the gauze. In a randomized study comparing gauze-
based and foam-based NPWT, Dorafshar et al. reported that
gauze-based NPWT provides a less painful option compared
with foam-based NPWT.30
This may be due to the lack of tissue ingrowth observed
with gauze. Similar observations were made by Fraccalvieri
et al.31 Researchers from Sweden compared the expression
of calcitonin gene-related peptide (CGRP) and substance P in
the wound bed following NPWT and foam or gauze dressing
removal. CGRP and substance P are neuropeptides that cause
inflammation and signal pain and are known to be released
when tissue trauma occurs. The results of study show that
both peptides were more abundant in the wound edge after
the removal of foam than the removal of gauze after NPWT.32
According to NPWT-EP recommendations, gauze may
be chosen in patients more susceptible to pain and may
be a means of reducing pain experienced during dressing
removal.12 Another way to reduce pain reported by the
patients during the dressing change is the installation of
anesthetic through the suction tubing 30 minutes before. In
two double-blind, randomized studies topical lidocaine ap-
plication was associated with lower score on the 0-10 visual
analog scale for pain during the NPWT sponge removal.33, 34
Some researchers have suggested that NPWT is not more
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painful than conventional dressing. Randomised controlled
trial performed by Vuerstaek et al. evaluated outcome in leg
ulcer patients receiving NPWT or conventional wound care
techniques. The pain levels were found to be similar in both
groups during the first 5 weeks of therapy, however, those
who received NPWT reported significantly less pain after
the fifth week. Authors suggest that although NPWT may be
just as painful as other wound treatments, the pain may be
less prolonged and only short-term.14
Figure 4. Patient no. 14 in Table 1; a,b) the wounds at the moment of
admission; c) the wounds bed filled with granulation tissue after 13 days of
NPWT; d, e) healing of only 70 % of applied skin grafts, regrafting was
needed on the marked area (black arrows).
V. CONCLUSIONS
This study describes effective and efficient use of NPWT
in the treatment of huge chronic venous ulcers. The limitation
of our study is the lack of control group and the small number
of patients. Application of negative pressure wound therapy
provided quick wound-bed preparation for surgical closure.
Moreover, the NPWT stimulates the process of anastomosis
creation between bed and the graft vessels and removes the
exudate that may hamper graft’s adhering. What are more
the bacteria that impair wound healing are eradicated by
the antimicrobial properties of silver impregnated dressings?
Therefore the NPWT combined with silver dressings demon-
strates an increase in graft take rate and improvement in graft
quality. Finally, that significantly reduces the time and costs
of wound treatment.
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